Remimazolam besylate for anesthesia and intensive care sedation in patients with malignancy: A narrative review of pharmacology, immune effects and clinical evidence

JCA Advances · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles